EMIS GROUP Aktie Logo
GB00B61D1Y04
A1CVN6
EMIS.L

EMIS GROUP Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2023, EMIS GROUP Aktie has already paid €0.49 in dividends. The last payout was in October 2023.

Financials

In the last year, EMIS GROUP Aktie had revenue of €197.79m and net profit of €37.41m
(EUR) 2022
YoY
Revenue 197.79m 1.11%
Gross profit 183.24m 1.42%
Net profit 37.41m 8.22%
EBITDA 64.76m 0.01%

Fundamentals

Metric Value
Market capitalization
€1.48bn
Number of shares
64.16m
52-week high/low
€23.30 - €14.99
Dividends No
Beta
-0.13
P/E ratio
36.26
PEG ratio
0.36
P/B ratio
8.52
P/S ratio
7.03

Company profile

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.

Name
EMIS GROUP Aktie
CEO
Andrew John Thorburn
Headquarters Leeds,
United Kingdom
Website
IPO
29/03/2010
Employees 1,560

Ticker symbols

Exchange Symbol
London Stock Exchange
EMIS.L
🍪

Parqet  uses cookies. Learn more